November’s IPO market struggled to take off amid a US government shutdown at the start of the month and a slump in tech stocks. Even still, eleven new listings managed to raise a combined $2.3 billion, below the month’s historical 10-year average...read more
Six IPOs debuted this week, raising a combined $1.8 billion. Four SPACs also listed. One IPO and seven SPACs submitted initial filings. Leading the pack, electric aircraft manufacturer Beta Technologies (BETA) priced its upsized IPO above the range to raise...read more
BillionToOne, which develops prenatal and oncology diagnostics with single-molecule sensitivity, raised $273 million by offering 4.6 million shares at $60, above the range of $49 to $55. The offering contains 0.7 million more shares than anticipated. At pricing,...read more
The long-awaited IPO pickup lost some of its steam in October, as the US government shutdown disrupted timelines and delayed deal activity. Twenty-two IPOs raised a combined $3.2 billion, in line with the 10-year historical average by deal count (21) but well...read more
Renaissance Capital's November IPO Market Update
November’s IPO market struggled to take off amid a US government shutdown at the start of the month and a slump in tech stocks. Even still, eleven new listings managed to raise a combined $2.3 billion, below the month’s historical 10-year average...read more
US IPO Weekly Recap: Beta Technologies leads 6 deal week to open November
Six IPOs debuted this week, raising a combined $1.8 billion. Four SPACs also listed. One IPO and seven SPACs submitted initial filings. Leading the pack, electric aircraft manufacturer Beta Technologies (BETA) priced its upsized IPO above the range to raise...read more
Molecular diagnostics company BillionToOne prices upsized IPO at $60, above the range
BillionToOne, which develops prenatal and oncology diagnostics with single-molecule sensitivity, raised $273 million by offering 4.6 million shares at $60, above the range of $49 to $55. The offering contains 0.7 million more shares than anticipated. At pricing,...read more
Renaissance Capital's October IPO Market Update
The long-awaited IPO pickup lost some of its steam in October, as the US government shutdown disrupted timelines and delayed deal activity. Twenty-two IPOs raised a combined $3.2 billion, in line with the 10-year historical average by deal count (21) but well...read more